摘要
Abstract
· AlM: To investigate the safety and effectiveness of semiconductor laser transscleral cyclophotocoagulation ( Tscpc) on refractory glaucomatous.
<br> · METHODS: A retrospective review of 33 patients ( 33 eyes ) whose eyes were diagnosed as refractory glaucomatous from March 2012 to March 2013 were treated with Tscpc (energy 1000 ~3000mW, time 2000 ~3000ms, range 270°~360°, count 20 ~40 ). Ocular symptoms, visual acuity, and intraocular pressure ( lOP) , ocular protomerite and complications were observed after Tscpc.Patients were followed up 6mo.
<br> · RESULTS: The pain sense of 32 patients ( 97%) disappeared or remarkably relieved at the final follow up. Mean pre-operative lOP was 50.26 ±9.37mmHg, which was significantly different from the final follow-up 6mo mean lOP 18.38±8.73mmHg (P<0.05).At three month postoperative, lOP of 2 cases ( 6%) was rise, and those patients were retreated with Tscpc. Complications included inflammation in anterior chamber reaction in 9 cases ( 27%) , hyphema 5 cases ( 15%) , conjunctival hemorrhage 2 cases ( 6%) . Bulbar conjunctival congestion and edema 12 cases ( 36%) , and atrophy of eyeball 1 case (3%).
<br> · CONCLUSlON: Semiconductor laser transscleral cyclophotocoagulation is a simple, safe and effective method in the treatment of refractory glaucoma.关键词
半导体激光/经巩膜睫状体光凝术/难治性青光眼Key words
semiconductor laser/transscleral cyclophotocoagulation/refractory glaucomatous
